Ted Monohon, Chief Accounting Officer & VP: Quince Therapeutics QNCX Sell · Filed 23/03/06

Trade details

Type: Insider sale
Amount: $1,833.58
Shares · price: 1,871 sh · $0.98 a share
Held after: 27,440 sh
Stock: Quince Therapeutics QNCX
Person: Ted MonohonChief Accounting Officer & VP
Trade date: 23/03/06
Filed: 23/03/06
Days to filing: 0 days

Sold 6.4% of holdings

Share of holding sold: 6.4%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/04~23/04/05

Ted Monohon's recent trades

No other trades yet.